Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
CRHBP |
corticotropin releasing hormone binding protein |
5q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IDA[1846945|18559919]
|
LTB |
lymphotoxin beta |
6p21.3 |
rSNP target |
0
|
IEA
|
IL1B |
interleukin 1 beta |
2q14 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IDA[12483741]; IMP[3493774]
|
CCK |
cholecystokinin |
3p22.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
CLIC1 |
chloride intracellular channel 1 |
6p21.3 |
rSNP target |
0
|
IDA[22664934]
|
NUCB2 |
nucleobindin 2 |
11p15.1 |
rSNP target |
0
|
IDA[16502470]
|
TNF |
tumor necrosis factor |
6p21.3 |
Mapped by Literature SNP |
1(1/0/0)
|
IDA[3932069|10443688|12594207|18355445]
|
ADCYAP1 |
adenylate cyclase activating polypeptide 1 (pituitary) |
18p11 |
Literature-origin |
6(0/6/0)
|
IEA
|
CAT |
catalase |
11p13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
NPY |
neuropeptide Y |
7p15.3 |
Literature-origin, Mapped by Literature SNP |
2(0/2/0)
|
IBA; ISS
|
APOC3 |
apolipoprotein C-III |
11q23.3 |
Mapped by LD-proxy |
0
|
IDA[11060345]
|
APOA1BP |
apolipoprotein A-I binding protein |
1q21 |
rSNP target |
0
|
ISS[22261194]
|
APOA5 |
apolipoprotein A-V |
11q23 |
rSNP target |
0
|
IDA[18635818|19121291]
|
SAAL1 |
serum amyloid A like 1 |
11p15.1 |
rSNP target |
0
|
IBA
|
APOB |
apolipoprotein B |
2p24-p23 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
ISS[22261194]
|
ACTC1 |
actin, alpha, cardiac muscle 1 |
15q14 |
rSNP target |
0
|
IDA[22664934|23580065]
|
CRP |
C-reactive protein, pentraxin-related |
1q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(2/1/0)
|
IDA[23544079]
|
NLGN1 |
neuroligin 1 |
3q26.32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IBA
|
APOA1 |
apolipoprotein A-I |
11q23-q24 |
Mapped by LD-proxy |
0
|
IDA[16502470|19433579|20551380|22664934]; ISS[22261194]
|
HIST2H2BE |
histone cluster 2, H2be |
1q21.2 |
rSNP target |
0
|
IDA[12860195]
|
LTA |
lymphotoxin alpha |
6p21.3 |
Mapped by Literature SNP |
0
|
IEA
|
IFNG |
interferon, gamma |
12q14 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IBA
|
IL1A |
interleukin 1 alpha |
2q14 |
rSNP target |
0
|
IDA[12746488]; IMP[3493774]
|
APOE |
apolipoprotein E |
19q13.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
IDA[16502470|20551380]
|
MTHFD2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
2p13.1 |
Mapped by LD-proxy, rSNP target |
0
|
IDA[22664934]
|
IL15RA |
interleukin 15 receptor subunit alpha |
10p15.1 |
rSNP target |
0
|
IEA
|
FASLG |
Fas ligand |
1q23 |
Literature-origin |
1(0/0/1)
|
IDA[18835034]
|